Allogene Therapeutics, a clinical-stage biotech company specializing in allogeneic CAR T cell therapies for cancer and autoimmune diseases, announced its participation in three investor conferences: TD Cowen Oncology Innovation Summit on May 26, Jefferies Global Healthcare Conference on June 3, and H.C. Wainwright Cell Therapy Virtual Conference on June 9. The company will webcast these events on its website, providing updates on its pipeline of off-the-shelf CAR T cell products aimed at delivering scalable, on-demand cell therapy. This engagement highlights Allogene's ongoing efforts to communicate progress and attract investor interest as it advances its novel therapies.
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
Alibaba and Baidu shares rose after Apple received approval from China's Cyberspace Administration to include Apple Intelligence, integrating Alibaba's Qwen AI model and Baidu's AI features into Apple devices in China. This partnership allows users t...
Ondo Finance has introduced the first tokenized stock representations backed by DTCC tokenized entitlements, joining major financial firms in a significant tokenization initiative. This move highlights Ondo's unique position in building infrastructur...
